E. Poplavska

Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 2009-13

H. Naci, A. Aggarwal, C. Davis, 2017, British Medical Journal.

Unbranded advertising of prescription medicines to the public by pharmaceutical companies

H. Leufkens, A. Mantel‐Teeuwisse, B. Mintzes, 2017 .

Use of generic medicines in Latvia: awareness, opinions and experiences of the population

E. Poplavska, Signe Mezinska, Ieva Salmane Kulikovska, 2019, Journal of Pharmaceutical Policy and Practice.

Knowledge about Disease, Medication Therapy, and Related Medication Adherence Levels among Patients with Hypertension

A. Gavrilova, E. Poplavska, Dace Bandere, 2019, Medicina.

Medical, pharmacy and nursing students in the Baltic countries: interactions with the pharmaceutical and medical device industries

B. Mintzes, E. Poplavska, Signe Mezinska, 2020, BMC Medical Education.

Pricing of oral generic cancer medicines in 25 European countries; findings and implications

Steven Simoens, Brian Godman, Guenka Petrova, 2019, Generics and Biosimilars Initiative Journal.

Role of multidimensional factors in the diagnosis and treatment of tonsillopharyngitis in primary care: a qualitative study

E. Poplavska, Ieva Rutkovska, Zane Linde-Ozola, 2022, BMC Primary Care.

Use of generic medicines in Latvia: awareness, opinions and experiences of the population

E. Poplavska, Signe Mezinska, Ieva Salmane Kulikovska, 2019, Journal of pharmaceutical policy and practice.

Disease awareness campaigns in printed and online media in Latvia: cross-sectional study on consistency with WHO ethical criteria for medicinal drug promotion and European standards

A. Mantel‐Teeuwisse, B. Mintzes, E. Poplavska, 2018, BMC Public Health.